If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: Markets Insider
Stemcyte: StemCyte Renews Contract with the California Umbilical Cord Blood Collection Program
BALDWIN PARK, Calif., May 13, 2022 /PRNewswire/ -- Southern California cord blood regenerative therapeutics company StemCyte has renewed their agr...
Read full article »
Stemcyte's Competitors
|
Stemcyte's News
|
Stemcyte's Financials
Follow
Followers on Owler
49
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO
Update CEO
CEO Approval Rating
- -/100
Read more
See Stemcyte company profile »
